Bharat Biotech Covaxin Demonstrates 78 Percent Efficacy In Treating Covid-19 Apr 21, 2021, 19:56 IST
The efficacy against severe COVID-19 disease was 100 per cent with an impact on reduction in hospitalizations.
The efficacy against asymptomatic COVID-19 infection was 70 per cent, suggesting decreased transmission in Covaxin recipients, it said.
HYDERABAD: Bharat Biotech-developed Covaxin demonstrated 78 percent efficacy in treating COVID-19 as per reports released by the company.
In a press release, the company stated that the overall interim clinical efficacy of 78 per cent and 100 per cent efficacy against severe COVID-19as per the phase 3 interim analysis results of the vaccine.
The efficacy against severe COVID-19 disease was 100 per cent with an impact on reduction in hospitalizations.